AdaptHealth Q2 2025 revenue $800.4M, net income $14.7M; lowers FY adjusted EBITDA guidance

AdaptHealth Corp.

2025-Q2 EPS reported $0.05 revenue$1,578,254,000

Net revenue $800.4M, down 0.7% YoY; net income $14.7M vs $19.4M in prior year.
Adjusted EBITDA $155.5M, down 5.9% YoY; year-to-date cash flow from ops $257.5M.
FY 2025 revenue guidance narrowed to $3.18B-$3.26B; adjusted EBITDA lowered to $642M-$682M.
Closed sales of certain incontinence and infusion assets in Wellness at Home segment.
Announces new capitated partnership with a major national healthcare system (no details).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.